The Leicester Cough Questionnaire in two phase 3 trials of gefapixant in chronic cough
S. Birring (London, United Kingdom), J. Smith (University of MancManchester, United Kingdom), A. Morice (Cottingham, United Kingdom), I. Pavord (Oxford, United Kingdom), P. Dicpinigaitis (Bronx, United States of America), L. Mcgarvey (Belfast, United Kingdom), A. Tzontcheva (Kenilworth, United States of America), Q. Li (Kenilworth, United States of America), A. Martin Nguyen (Kenilworth, United States of America), J. Schelfhout (Kenilworth, United States of America), D. Muccino (Kenilworth, United States of America), C. La Rosa (Kenilworth, United States of America)
Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Birring (London, United Kingdom), J. Smith (University of MancManchester, United Kingdom), A. Morice (Cottingham, United Kingdom), I. Pavord (Oxford, United Kingdom), P. Dicpinigaitis (Bronx, United States of America), L. Mcgarvey (Belfast, United Kingdom), A. Tzontcheva (Kenilworth, United States of America), Q. Li (Kenilworth, United States of America), A. Martin Nguyen (Kenilworth, United States of America), J. Schelfhout (Kenilworth, United States of America), D. Muccino (Kenilworth, United States of America), C. La Rosa (Kenilworth, United States of America). The Leicester Cough Questionnaire in two phase 3 trials of gefapixant in chronic cough. 1587
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Validity and precision of the Leicester Cough Questionnaire in COPD patients with chronic cough Source: Annual Congress 2010 - COPD: symptoms and staging Year: 2010
The Cough Severity Diary in a pooled analysis of two, phase 3 trials of gefapixant in chronic cough Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2 Year: 2021
The Leicester Cough Monitor: preliminary validation of an automated cough detection system in chronic cough Source: Eur Respir J 2008; 31: 1013-1018 Year: 2008
Defining health states with visual analogue scale and Leicester Cough Questionnaire in chronic cough Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status Year: 2021
Translation, validity and reliability of the Leicester cough questionnaire into Swedish in COPD Source: International Congress 2016 – Physiotherapy management of the ill but spontaneously-breathing adult patient Year: 2016
Symptom management: dyspnoea and cough Source: Eur Respir Monogr 2016; 71: 218-229 Year: 2016
Evaluation of vocal performance questionnaire in people with chronic refractory cough Source: Annual Congress 2013 –Assessment methods involved in the physiotherapy treatment in different patient populations Year: 2013
The assessment of cough severity with the Leicester cough monitor Source: Annual Congress 2009 - Pleural and parenchymal diseases Year: 2009
Assessment of cough frequency to inhaled mannitol using ambulatory acoustic cough recording Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015
Chronic cough and asthma-like symptoms – Not always asthma Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013
Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis Source: Eur Respir J 2009; 34: 125-131 Year: 2009
Concurrent validation of a Dutch translation of the Leicester Cough Questionnaire Source: Eur Respir J 2005; 26: Suppl. 49, 301s Year: 2005
Reliability and validity of a Turkish version of Leicester cough questionnaire Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015
Repercussion of cough in sleep quality in COPD exacerbation Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014
Assessment of symptoms: Cough reflex and LAR Source: Research Seminar 2013 - Translational animal models of asthma Year: 2013
Validity of questions used to assess chronic cough in epidemiological surveys Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma Year: 2013
Validation of a Spanish version of the Leicester cough questionnaire in adult patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions Year: 2013
Development and validation of an innovative self-administered computerized (SAC) version of baseline/transition dyspnea index (BDI/TDI) for evaluating breathlessness in patients with COPD: The BLAZE study Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013
Effect of cromolyn inhaler on resistant neutrophilic cough variant of asthma, A phase two clinical trial Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014